Original article
Characterization of and costs associated to the profile of patients with type 2 diabetes treated with metformin who are added a second oral antidiabetic drug: A population study
Caracterización y costes asociados al perfil del paciente con diabetes tipo 2 en tratamiento con metformina al que se le añade un segundo fármaco antidiabético oral: estudio de base poblacional
Antoni Sicras-Mainara,
, Beatriu Font-Ramosb, Cecilia Roldán-Suárezc, Ruth Navarro-Artiedad, Jordi Ibáñez-Nollae
Corresponding author
a Dirección de Planificación, Badalona Serveis Assistencials SA, Badalona, Barcelona, Spain
b Health Outcomes Research, Novartis Farmacéutica SA, Barcelona, Spain
c Medical Advisord Cardiologist, Novartis Farmacéutica SA, Barcelona, Spain
d Documentación Médica, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain
e Dirección médica, Badalona Serveis Assistencials SA, Badalona, Barcelona, Spain
Read
3043
Timeswas read the article
812
Total PDF
2231
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 26 | 5 | 31 |
| 2025 11 | 67 | 13 | 80 |
| 2025 10 | 38 | 9 | 47 |
| 2025 9 | 45 | 11 | 56 |
| 2025 8 | 44 | 7 | 51 |
| 2025 7 | 61 | 8 | 69 |
| 2025 6 | 28 | 3 | 31 |
| 2025 5 | 35 | 5 | 40 |
| 2025 4 | 34 | 3 | 37 |
| 2025 3 | 44 | 3 | 47 |
| 2025 2 | 39 | 8 | 47 |
| 2025 1 | 25 | 4 | 29 |
| 2024 12 | 26 | 5 | 31 |
| 2024 11 | 26 | 2 | 28 |
| 2024 10 | 17 | 4 | 21 |
| 2024 9 | 43 | 8 | 51 |
| 2024 8 | 34 | 6 | 40 |
| 2024 7 | 16 | 4 | 20 |
| 2024 6 | 18 | 3 | 21 |
| 2024 5 | 16 | 3 | 19 |
| 2024 4 | 25 | 7 | 32 |
| 2024 3 | 29 | 6 | 35 |
| 2024 2 | 15 | 2 | 17 |
| 2024 1 | 24 | 2 | 26 |
| 2023 12 | 20 | 4 | 24 |
| 2023 11 | 19 | 3 | 22 |
| 2023 10 | 18 | 8 | 26 |
| 2023 9 | 7 | 5 | 12 |
| 2023 8 | 11 | 5 | 16 |
| 2023 7 | 12 | 4 | 16 |
| 2023 6 | 13 | 2 | 15 |
| 2023 5 | 15 | 4 | 19 |
| 2023 4 | 13 | 4 | 17 |
| 2023 3 | 8 | 0 | 8 |
| 2023 2 | 8 | 4 | 12 |
| 2023 1 | 16 | 4 | 20 |
| 2022 12 | 13 | 9 | 22 |
| 2022 11 | 13 | 5 | 18 |
| 2022 10 | 15 | 14 | 29 |
| 2022 9 | 21 | 7 | 28 |
| 2022 8 | 18 | 10 | 28 |
| 2022 7 | 20 | 10 | 30 |
| 2022 6 | 23 | 7 | 30 |
| 2022 5 | 20 | 5 | 25 |
| 2022 4 | 12 | 9 | 21 |
| 2022 3 | 20 | 7 | 27 |
| 2022 2 | 9 | 8 | 17 |
| 2022 1 | 16 | 5 | 21 |
| 2021 12 | 17 | 12 | 29 |
| 2021 11 | 12 | 10 | 22 |
| 2021 10 | 22 | 17 | 39 |
| 2021 9 | 11 | 8 | 19 |
| 2021 8 | 9 | 5 | 14 |
| 2021 7 | 9 | 7 | 16 |
| 2021 6 | 24 | 8 | 32 |
| 2021 5 | 19 | 9 | 28 |
| 2021 4 | 34 | 20 | 54 |
| 2021 3 | 12 | 5 | 17 |
| 2021 2 | 12 | 7 | 19 |
| 2021 1 | 13 | 11 | 24 |
| 2020 12 | 17 | 9 | 26 |
| 2020 11 | 14 | 2 | 16 |
| 2020 10 | 13 | 6 | 19 |
| 2020 9 | 8 | 10 | 18 |
| 2020 8 | 8 | 8 | 16 |
| 2020 7 | 19 | 12 | 31 |
| 2020 6 | 13 | 7 | 20 |
| 2020 5 | 12 | 4 | 16 |
| 2020 4 | 9 | 5 | 14 |
| 2020 3 | 11 | 2 | 13 |
| 2020 2 | 5 | 3 | 8 |
| 2020 1 | 17 | 8 | 25 |
| 2019 12 | 19 | 7 | 26 |
| 2019 11 | 9 | 6 | 15 |
| 2019 10 | 8 | 6 | 14 |
| 2019 9 | 8 | 6 | 14 |
| 2019 8 | 9 | 12 | 21 |
| 2019 7 | 10 | 12 | 22 |
| 2019 6 | 23 | 19 | 42 |
| 2019 5 | 64 | 42 | 106 |
| 2019 4 | 22 | 23 | 45 |
| 2019 3 | 9 | 3 | 12 |
| 2019 2 | 13 | 7 | 20 |
| 2019 1 | 9 | 4 | 13 |
| 2018 12 | 13 | 6 | 19 |
| 2018 11 | 15 | 1 | 16 |
| 2018 10 | 16 | 4 | 20 |
| 2018 9 | 19 | 2 | 21 |
| 2018 8 | 29 | 13 | 42 |
| 2018 7 | 14 | 2 | 16 |
| 2018 6 | 4 | 1 | 5 |
| 2018 5 | 4 | 7 | 11 |
| 2018 4 | 16 | 1 | 17 |
| 2018 3 | 2 | 0 | 2 |
| 2018 2 | 4 | 1 | 5 |
| 2018 1 | 7 | 3 | 10 |
| 2017 12 | 6 | 4 | 10 |
| 2017 11 | 9 | 3 | 12 |
| 2017 10 | 9 | 6 | 15 |
| 2017 9 | 14 | 1 | 15 |
| 2017 8 | 18 | 8 | 26 |
| 2017 7 | 14 | 2 | 16 |
| 2017 6 | 22 | 18 | 40 |
| 2017 5 | 20 | 0 | 20 |
| 2017 4 | 21 | 4 | 25 |
| 2017 3 | 19 | 23 | 42 |
| 2017 2 | 17 | 5 | 22 |
| 2017 1 | 11 | 1 | 12 |
| 2016 12 | 19 | 9 | 28 |
| 2016 11 | 14 | 1 | 15 |
| 2016 10 | 32 | 6 | 38 |
| 2016 9 | 17 | 3 | 20 |
| 2016 8 | 18 | 6 | 24 |
| 2016 7 | 19 | 1 | 20 |
| 2016 6 | 12 | 6 | 18 |
| 2016 5 | 8 | 2 | 10 |
| 2016 4 | 15 | 10 | 25 |
| 2016 3 | 15 | 3 | 18 |
| 2016 2 | 20 | 9 | 29 |
| 2016 1 | 13 | 8 | 21 |
| 2015 12 | 12 | 8 | 20 |
| 2015 11 | 16 | 7 | 23 |
| 2014 4 | 0 | 1 | 1 |
Show all
